Researchers at Temple University Have Reported New Data on Urothelial Cancer (Clinical Outcomes of Metastatic Urothelial Carcinoma Patients Discontinuing Enfortumab Vedotin Due to Toxicity and/or Clinical Response)

Media coverage

• Title	Researchers at Temple University Have Reported New Data on Urothelial Cancer (Clinical Outcomes of Metastatic Urothelial Carcinoma Patients Discontinuing Enfortumab Vedotin Due to Toxicity and/or Clinical Response)
  Media name/outlet	Immunotherapy Daily
  Country/Territory	United States
  Date	09/2/26
  Persons	Elizabeth R. Plimack, Pooja Ghatalia, Matthew R. Zibelman, Daniel Geynisman